Lichen International Limited (LICN)
NASDAQ: LICN · Real-Time Price · USD
3.150
+0.140 (4.65%)
At close: Mar 9, 2026, 4:00 PM EDT
3.140
-0.010 (-0.32%)
After-hours: Mar 9, 2026, 4:00 PM EDT

Lichen International Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
37.6441.4839.7633.8134.330.67
Revenue Growth (YoY)
-10.23%4.32%17.61%-1.43%11.83%-2.96%
Cost of Revenue
16.3415.815.4413.6113.8211.83
Gross Profit
21.325.6724.3220.1920.4818.84
Selling, General & Admin
32.830.2312.069.549.1810.05
Total Operating Expenses
32.830.2312.069.549.1810.05
Operating Income
-11.5-4.5512.2610.6511.38.79
Interest Income
0.160.160.040.060.030.1
Other Non-Operating Income (Expense)
-3.690.22-0.710.030.190.11
Total Non-Operating Income (Expense)
-3.530.38-0.670.090.220.21
Pretax Income
-15.03-4.1711.5910.7411.519
Provision for Income Taxes
1.041.953.252.923.052.59
Net Income
-16.26-6.148.347.828.466.41
Minority Interest in Earnings
0.16-0.02----
Net Income to Common
-16.26-6.148.347.828.466.41
Net Income Growth
--6.65%-7.61%32.07%-9.38%
Shares Outstanding (Basic)
100011
Shares Outstanding (Diluted)
100011
Shares Change (YoY)
303.62%273.21%17.78%-77.50%--49.08%
EPS (Basic)
-21.35-12.4162.9369.4910.0010.00
EPS (Diluted)
-21.35-12.4162.9369.4910.0010.00
EPS Growth
---9.45%594.93%-38.89%
Free Cash Flow
-11.11-5.61-2.658.827.288.35
Free Cash Flow Growth
---21.16%-12.86%-5.42%
Free Cash Flow Per Share
----14.5516.70
Gross Margin
56.60%61.90%61.17%59.73%59.70%61.42%
Operating Margin
-30.55%-10.97%30.83%31.50%32.94%28.65%
Profit Margin
-42.69%-14.76%20.97%23.13%24.67%20.89%
FCF Margin
-29.52%-13.52%-6.66%26.08%21.22%27.23%
EBITDA
-8.26-1.5615.2513.3813.8411.03
EBITDA Margin
-21.95%-3.76%38.37%39.58%40.35%35.98%
EBIT
-11.5-4.5512.2610.6511.38.79
EBIT Margin
-30.55%-10.97%30.83%31.50%32.94%28.65%
Effective Tax Rate
-6.89%-46.69%28.05%27.22%26.51%28.78%
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q